400 related articles for article (PubMed ID: 9371774)
1. P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity.
Mechetner EB; Schott B; Morse BS; Stein WD; Druley T; Davis KA; Tsuruo T; Roninson IB
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):12908-13. PubMed ID: 9371774
[TBL] [Abstract][Full Text] [Related]
2. Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity.
Druley TE; Stein WD; Roninson IB
Biochemistry; 2001 Apr; 40(14):4312-22. PubMed ID: 11284687
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation.
Druley TE; Stein WD; Ruth A; Roninson IB
Biochemistry; 2001 Apr; 40(14):4323-31. PubMed ID: 11284688
[TBL] [Abstract][Full Text] [Related]
4. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
Ruth A; Stein WD; Rose E; Roninson IB
Biochemistry; 2001 Apr; 40(14):4332-9. PubMed ID: 11284689
[TBL] [Abstract][Full Text] [Related]
5. Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity.
Julien M; Gros P
Biochemistry; 2000 Apr; 39(15):4559-68. PubMed ID: 10758006
[TBL] [Abstract][Full Text] [Related]
6. Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1).
Chufan EE; Kapoor K; Sim HM; Singh S; Talele TT; Durell SR; Ambudkar SV
PLoS One; 2013; 8(12):e82463. PubMed ID: 24349290
[TBL] [Abstract][Full Text] [Related]
7. Conformational changes of P-glycoprotein by nucleotide binding.
Wang G; Pincheira R; Zhang M; Zhang JT
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):897-904. PubMed ID: 9396736
[TBL] [Abstract][Full Text] [Related]
8. Effects of ATP depletion and phosphate analogues on P-glycoprotein conformation in live cells.
Goda K; Nagy H; Mechetner E; Cianfriglia M; Szabó G
Eur J Biochem; 2002 Jun; 269(11):2672-7. PubMed ID: 12047375
[TBL] [Abstract][Full Text] [Related]
9. Both ATP sites of human P-glycoprotein are essential but not symmetric.
Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM
Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234
[TBL] [Abstract][Full Text] [Related]
10. Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis.
Zoghbi ME; Mok L; Swartz DJ; Singh A; Fendley GA; Urbatsch IL; Altenberg GA
J Biol Chem; 2017 Dec; 292(50):20412-20424. PubMed ID: 29018094
[TBL] [Abstract][Full Text] [Related]
11. Importance of the conserved Walker B glutamate residues, 556 and 1201, for the completion of the catalytic cycle of ATP hydrolysis by human P-glycoprotein (ABCB1).
Sauna ZE; Müller M; Peng XH; Ambudkar SV
Biochemistry; 2002 Nov; 41(47):13989-4000. PubMed ID: 12437356
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
[TBL] [Abstract][Full Text] [Related]
13. About a switch: how P-glycoprotein (ABCB1) harnesses the energy of ATP binding and hydrolysis to do mechanical work.
Sauna ZE; Ambudkar SV
Mol Cancer Ther; 2007 Jan; 6(1):13-23. PubMed ID: 17237262
[TBL] [Abstract][Full Text] [Related]
14. Interactions and cooperativity between P-glycoprotein structural domains determined by thermal unfolding provides insights into its solution structure and function.
Yang Z; Zhou Q; Mok L; Singh A; Swartz DJ; Urbatsch IL; Brouillette CG
Biochim Biophys Acta Biomembr; 2017 Jan; 1859(1):48-60. PubMed ID: 27783926
[TBL] [Abstract][Full Text] [Related]
15.
Futamata R; Ogasawara F; Ichikawa T; Kodan A; Kimura Y; Kioka N; Ueda K
J Biol Chem; 2020 Apr; 295(15):5002-5011. PubMed ID: 32111736
[TBL] [Abstract][Full Text] [Related]
16. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
[TBL] [Abstract][Full Text] [Related]
17. Insights Into the Molecular Mechanism of Triptan Transport by P-glycoprotein.
Wilt LA; Nguyen D; Roberts AG
J Pharm Sci; 2017 Jun; 106(6):1670-1679. PubMed ID: 28283434
[TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.
Mechetner EB; Roninson IB
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5824-8. PubMed ID: 1352877
[TBL] [Abstract][Full Text] [Related]
19. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
[TBL] [Abstract][Full Text] [Related]
20. Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation.
Maki N; Hafkemeyer P; Dey S
J Biol Chem; 2003 May; 278(20):18132-9. PubMed ID: 12642584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
